Despite the lack of large-scale clinical trials, circulating F-circEA offers a new perspective in the recognition of the mechanism of EML4-ALK translocation in NSCLC and is promising as a liquid biopsy biomarker [162]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.